Elicera Therapeutics AB
ELIC | ST
Overview
Corporate Details
- ISIN(s):
- SE0015382080 (+1 more)
- LEI:
- 549300I35L0R4INBFG27
- Country:
- Sweden
- Address:
- C/O Elicera Therapeutics AB, 402 24 Göteborg
- Website:
- https://elicera.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Elicera Therapeutics AB develops immuno-oncology therapies based on CAR T-cell technology. They target various cancer indications.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Elicera Therapeutics AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Elicera Therapeutics AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Elicera Therapeutics AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Margareth Jorvid | Other | Other | 21,700 | 40,145.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MedinCell S.A. | France | MEDCL | |
|
Mendus | Sweden | IMMU | |
|
Merchavia Holdings and Investments Ltd. | Israel | MRHL | |
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD | |
|
Nanexa AB | Sweden | NANEXA |